Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterNo recent work listed

Sam H. Whiting

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-8736-0583; OpenAlex author ID A5013695327. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Adenocarcinoma. Last author DOI 10.1097/mpa.0000000000002253↗
  2. Lapatinib and gemcitabine for metastatic pancreatic cancer. A phase II study. Co-author DOI 10.1097/coc.0b013e3181d26b01↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gentry G. King · 1 shared paper, 2023 · strength 0.16
  2. Venu Gopal Pillarisetty · 1 shared paper, 2023 · strength 0.16
  3. Jonathan G. Sham · 1 shared paper, 2023 · strength 0.16
  4. Andrew L. Coveler · 1 shared paper, 2023 · strength 0.16
  5. David Bing Zhen · 1 shared paper, 2023 · strength 0.16
  6. Elena Gabriela Chiorean · 1 shared paper, 2023 · strength 0.16
  7. Terence Tai-Weng Sio · 1 shared paper, 2011 · strength 0.02
  8. Weijing Sun · 1 shared paper, 2011 · strength 0.02
  9. Thomas J. Miner · 1 shared paper, 2011 · strength 0.02
  10. Howard P. Safran · 1 shared paper, 2011 · strength 0.02
  11. Nathan Bahary · 1 shared paper, 2011 · strength 0.02
  12. Charles D. Lopez · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.